Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05531760
Other study ID # 2022-10Obs-CHRMT
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 1, 2022
Est. completion date June 1, 2022

Study information

Verified date September 2022
Source Centre Hospitalier Régional Metz-Thionville
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of this study was to identify the predictive factors of graft detachment after Descemet Membrane Endothelial Keratoplasty (DMEK) surgery. This retrospective study was conducted on patients aged 18 years, with Fuchs' dystrophy (FECD) or pseudophakic bullous keratopathy (PBK), who were scheduled for DMEK or triple-DMEK (combined phacoemulsification and DMEK surgery). Patients with a history of surgery other than cataract surgery were excluded. The study was conducted between 2014 and 2022 and follow-up was for 3 months. The characteristics of patients with and without graft detachment following surgery were compared using logistic regression.


Recruitment information / eligibility

Status Completed
Enrollment 170
Est. completion date June 1, 2022
Est. primary completion date June 1, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients over 18 years of age with DMEK surgery Exclusion Criteria: - all associated eye surgery other than cataract surgery - all existing anterior segment anomalies

Study Design


Intervention

Procedure:
Descemet Membrane Endothelial Keratoplasty
DMEK-operated eyes

Locations

Country Name City State
France CHR Metz-Thionville/Hopital de Mercy Metz

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Régional Metz-Thionville

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Appearence of the graft on anterior segment optical coherence tomography (AS OCT) examination clinical examination and anterior segment optical coherence tomography (AS OCT) examination (appearence of the graft) up to 3 months after surgery
See also
  Status Clinical Trial Phase
Recruiting NCT04191629 - Phase 1 Study to Evaluate the Safety and Tolerability of EO1404 in the Treatment of Corneal Edema Phase 1
Recruiting NCT04387331 - The Postoperative Head Position as a Predictor of the Surgical Outcome After DMEK
Not yet recruiting NCT05716945 - The OPTIMISE Study Phase 4
Recruiting NCT04258787 - OCT in Fuchs' Dystrophy
Active, not recruiting NCT04894110 - Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema Phase 1
Completed NCT04420429 - The Effect Of Preoperative Parameters On Success After DMEK Surgery
Recruiting NCT05636579 - Study to Assess Safety and Tolerability of Multiple Doses of EO2002 Phase 1
Completed NCT04520321 - A Phase 1/ Phase 2 Study of TTHX1114(NM141) Phase 1/Phase 2
Recruiting NCT04344522 - Descemet Membrane Endothelial Keratoplasty Combined With Intraocular Lens Exchange: Sequential Versus Combined Surgery N/A
Recruiting NCT05436665 - The Belgian Endothelial Surgical Transplant of the Cornea N/A
Not yet recruiting NCT00623584 - Comparison of Corneal Grafts Cultured in Serum-free Versus Corneal Grafts Cultured in Serum Supplemented Culture Media N/A